- What Certification in Oncology Actually Is
- Who Certifies It and Why That Matters
- Who Can Sit for the Exam
- Exam Format and Scoring
- The 17 Content Areas and Their Weights
- Fees, Deadlines, and Audit Mechanics
- Staying Certified: The Ten-Year Term and OCC
- AOBIM vs ABIM: Keeping the Credentials Straight
- Sequencing Your Preparation Around the Blueprint
- Frequently Asked Questions
- Certification in Oncology is an osteopathic subspecialty credential from the American Osteopathic Board of Internal Medicine (AOBIM), not an ABIM exam.
- The initial written exam has 300 multiple-choice questions over seven hours; passing requires a scaled score of at least 500.
- Hematologic malignancies is the heaviest domain at 15-19%, followed by Genitourinary tumors at 10-14%.
- The initial exam fee is $800; a late surcharge adds $240, for a $1,040 total.
What Certification in Oncology Actually Is
When people ask "what is oncology?" in a clinical context, they usually mean the medical field devoted to diagnosing and treating cancer. On this site, though, the question has a narrower answer. Certification in Oncology is a physician subspecialty credential awarded to osteopathic internists who have completed oncology fellowship training and passed a written examination designed to verify subspecialty-level knowledge.
It is a distinct credential, not a catch-all label for every cancer-related qualification. It is not ABIM Medical Oncology, and it is not a combined hematology-oncology examination. Candidates who pursue it are demonstrating mastery of the specific content outline published by their certifying board, covering everything from tumor-site-specific management to chemotherapy toxicity, paraneoplastic syndromes, and palliative care ethics.
If you are looking for broader definitions, our pages on what Oncology certification is and the meaning of Oncology cover the terminology, while this article focuses on how the credential works in practice.
Who Certifies It and Why That Matters
The certifying body is the American Osteopathic Board of Internal Medicine (AOBIM), with certification approval through the American Osteopathic Association (AOA). This is the osteopathic certification pathway, and it has its own eligibility rules, scoring scale, fee schedule, exam administration, and maintenance requirements.
For candidates, this affects practical decisions: which question bank to trust, which blueprint to study against, and which renewal pathway to plan for. A resource that maps its explanations to the AOBIM Oncology outline will serve you better than one repurposed from another board's exam.
Who Can Sit for the Exam
Eligibility is built around three things: foundational board certification, subspecialty training, and professional standing. The core requirements include:
- AOA board certification in internal medicine
- Two years of an ACGME-accredited or AOA-recognized Oncology or Hematology/Oncology fellowship
- An active medical license
- Ethical standing
- A completed application with program-director verification
There is also a combined-training route. A qualifying three-year combined or separate hematology/oncology training path can support applications for the separate Hematology and Oncology examinations. That matters if you trained in a combined program and plan to pursue both credentials as distinct certifications. For the full checklist, see our guide to Oncology requirements and how to qualify.
Exam Format and Scoring
The initial written examination contains 300 multiple-choice questions and lasts seven hours. That is a long sitting, and endurance is a real variable. Candidates should practice sustained concentration across extended sessions, not just short quiz blocks.
How the score works
Passing requires a scaled score of at least 500 on the AOA 200-800 scale. This is the point that trips up many candidates: 500 is not a raw percentage of correct answers. Scaled scoring translates performance onto a common scale so that results remain comparable across different exam forms. You cannot convert "I need 500" into "I need to get X% right" by simple arithmetic. For a deeper treatment, read our breakdown of the Oncology passing score.
What the questions test
As a subspecialty board exam, questions emphasize clinical judgment: selecting the next best step in management, recognizing a toxicity pattern, interpreting a presentation that suggests a paraneoplastic process, or choosing among therapeutic strategies for a given tumor type and stage. Expect clinical vignettes more than isolated fact recall. If you are weighing the exam's demands, our difficulty guide and pass rate discussion add context.
The 17 Content Areas and Their Weights
The exam draws from 17 content areas, each with an official percentage range. These are ranges, not fixed counts, so treat them as indicators of emphasis rather than exact question numbers. The full table:
| Content Area | Official Range |
|---|---|
| Hematologic malignancies | 15-19% |
| Genitourinary tumors | 10-14% |
| Gastrointestinal tumors | 6-10% |
| Chemotherapy toxicity | 6-10% |
| Breast tumors | 5-9% |
| Supportive care/palliative/ethics | 5-9% |
| Thoracic tumors | 4-8% |
| Paraneoplastic syndromes | 4-8% |
| Gynecologic tumors | 3-7% |
| Pharmacology/cancer biology/cancer genetics | 2-6% |
| Pancreatic/liver cancer | 2-6% |
| Prevention/screening | 2-6% |
| Skin cancer | 1-5% |
| Head and neck cancer | 1-5% |
| Bone/soft tissue/sarcoma | 1-5% |
| Opportunistic infection | 1-4% |
| Cancer trials | 1-3% |
For a domain-by-domain walkthrough, see Oncology Exam Domains: Complete Guide to All 17 Content Areas. Here is what the weighting means in practice.
Hematologic Malignancies (15-19%)
The single largest domain. A candidate who is shaky here is exposed to a large share of the exam.
- Leukemias, lymphomas, and plasma cell disorders as a cluster, not three isolated topics
- Diagnostic reasoning: which findings distinguish one entity from another
- Treatment selection and the toxicities that follow from it
Genitourinary Tumors (10-14%)
The second-heaviest domain, large enough that it deserves its own dedicated study block rather than a quick skim.
- Staging-driven management decisions
- Choosing between surveillance, local therapy, and systemic therapy
- Recognizing treatment-related complications specific to this tumor group
Chemotherapy Toxicity (6-10%) and Supportive Care/Palliative/Ethics (5-9%)
These two domains reward clinical pattern recognition and judgment rather than memorization of tumor-specific protocols.
- Linking an agent to its characteristic organ toxicity and the appropriate response
- Symptom control, goals-of-care communication, and ethical reasoning in advanced illness
Smaller Domains That Still Matter
Paraneoplastic syndromes (4-8%) and Pharmacology/cancer biology/cancer genetics (2-6%) are modest individually but rich in question-writing material. Cancer trials (1-3%) and Opportunistic infection (1-4%) are the smallest areas, yet each can still contribute several questions across a 300-item exam.
Key Takeaway
Do not substitute midpoints or guess at counts. Use the official ranges as a prioritization tool: weight your hours toward the large domains, but never leave the small ones at zero. Our Oncology cheat sheet is useful for a final review across all 17.
Fees, Deadlines, and Audit Mechanics
The fee structure is simple but unforgiving about timing. All figures are in USD:
| Item | Amount |
|---|---|
| Initial examination | $800 |
| Late surcharge | $240 |
| Examination plus late surcharge | $1,040 |
| Optional score audit | $200 |
The $1,040 figure is simply the $800 exam fee plus the $240 late surcharge. Applying on time saves you the surcharge entirely. If you want to review how score reporting works, the optional score audit costs $200 and must be requested within one month of the results. That window is short, so decide in advance whether you would ever use it rather than debating after the fact.
For a complete pricing picture, including how these fees fit into the broader financial picture of subspecialty certification, see our Oncology certification cost breakdown, and check exam dates and deadlines before you plan your application timeline.
Staying Certified: The Ten-Year Term and OCC
Passing the initial exam is not the end of the process. Certification carries a ten-year term, conditional on participation in Osteopathic Continuous Certification (OCC). Think of the initial exam as the entry point and OCC as the ongoing obligation.
Requirements for the 2025-2027 cycle
For time-limited diplomates in the 2025-2027 cycle, the requirements include:
- 60 CME credits over three years
- Of those, 15 Category 1 and/or Category 1-A credits
- One quality-improvement activity attestation per three-year cycle
- Active licensure
The OCC examination route
Oncology remains on the remotely proctored subspecialty OCC examination route, offered annually in August. Diplomates may begin that examination two years before certificate expiration. A successful early renewal extends from the existing certificate's expiration date, so testing early does not cost you remaining time on your current certificate.
AOBIM vs ABIM: Keeping the Credentials Straight
Because the names sound similar, candidates and employers sometimes conflate the osteopathic and allopathic subspecialty pathways. The key distinctions relevant to this site:
| Aspect | Certification in Oncology (AOBIM) | Other Pathways |
|---|---|---|
| Certifying body | AOBIM, with approval through the AOA | Different boards, different rules |
| Scoring scale | AOA 200-800 scaled; 500 to pass | Do not assume the same scale |
| Blueprint | 17 content areas with official ranges | Do not import another blueprint |
| Maintenance | OCC, with annual August remote subspecialty exam route | Separate maintenance programs |
The practical takeaway is to study against the AOBIM outline and nothing else. Mixing in another board's weights or fee schedule will produce a preparation plan built on the wrong assumptions.
Sequencing Your Preparation Around the Blueprint
Because the blueprint is unevenly weighted, the most effective approach is to let the domain ranges dictate when you study what. Here is one way to structure an eight-week lead-in, tied directly to the content areas:
Hematologic malignancies
- Largest domain (15-19%), so front-load it while your energy is highest
- Build your own comparison charts across entities
Genitourinary, gastrointestinal, and breast tumors
- Combined, these carry a large share of the exam
- Focus on staging-driven management decisions
Chemotherapy toxicity, supportive care/palliative/ethics, and paraneoplastic syndromes
- Judgment-heavy domains that benefit from vignette practice
Remaining tumor sites, pharmacology/genetics, prevention, trials, and full-length practice
- Sweep the small domains, then rehearse seven-hour endurance
For a fuller plan, our Oncology study guide goes deeper, and you can pair it with original practice questions on the main practice test site. Practice content mapped to the AOBIM Oncology outline, with original questions and explanations, helps you test yourself against the actual structure of the exam rather than a generic oncology question set.
If you are still deciding whether to pursue the credential, consider the career side as well: whether the certification is worth it, earnings considerations, and where oncology jobs are found. When you are ready to drill, return to the practice question bank and work through timed blocks.
Frequently Asked Questions
The American Osteopathic Board of Internal Medicine (AOBIM) issues it, with certification approval through the American Osteopathic Association (AOA). It is separate from ABIM Medical Oncology and from combined hematology-oncology examinations.
The initial written examination has 300 multiple-choice questions and lasts seven hours. Plan your preparation to include sustained, full-length practice so the length does not catch you off guard.
You need a scaled score of at least 500 on the AOA 200-800 scale. This is not a raw percentage of correct answers, so you cannot convert it into a simple percent-correct target.
The initial examination fee is $800. A late surcharge of $240 brings the total to $1,040. An optional score audit costs $200 and must be requested within one month of receiving results.
Certification has a ten-year term, conditional on Osteopathic Continuous Certification (OCC). Oncology uses a remotely proctored subspecialty OCC examination route offered annually in August, which diplomates may begin two years before certificate expiration.